Issued by the National Medical Products Administration and directly tied to medical device registration and transition work.
Test Systems
GtestWorks Automated Testing Platform
VectWorks 3.0 Electrical Performance Test Software
This page provides a structured interpretation of YY 9706.102-2021, the EMC collateral standard for medical electrical equipment, covering standard positioning, essential concepts, intended electromagnetic environments, emission and immunity test requirements, differences from YY 0505-2012, and implementation priorities for medical device manufacturers.
If you are preparing for a standard transition, registration submission, or EMC test planning, start with the standard profile, intended environment, and immunity sections. If your focus is engineering execution and corrective action, jump directly to the comparison and implementation sections.
YY 9706.102-2021 is the core EMC collateral standard for medical electrical equipment. It sets general electromagnetic compatibility requirements and test methods for the basic safety and essential performance of ME equipment and ME systems. Compared with YY 0505-2012, the new version places stronger emphasis on risk management, essential performance protection, and immunity under realistic wireless environments.
Issued by the National Medical Products Administration and directly tied to medical device registration and transition work.
Once the new version took effect, the former EMC collateral standard for medical electrical equipment was superseded.
The technical framework aligns with mainstream international EMC practice for medical electrical equipment.
The target is no longer just preventing shutdown or lockup, but preventing degradation of clinically critical functions.
YY 9706.102-2021 does not simply define emission limits and immunity test items. It also requires the manufacturer to define essential performance through risk management, declare the intended electromagnetic environment, and integrate EMC design and accompanying-document obligations into a single compliance path.
For medical devices, EMC is not only about whether the product can power on. It also affects measurement accuracy, alarm behavior, therapy continuity, and patient safety, which is why the standard addresses essential performance and recovery expectations explicitly.
For medical device manufacturers, YY 9706.102-2021 is no longer a late-stage EMC add-on. It must be addressed from product definition through hardware design, software monitoring, verification, and registration documentation.
This section helps teams confirm the standard's basic attributes, replacement relationship, and scope boundaries, so they can decide whether a project must be designed and verified against this EMC standard.
| Item | Details |
|---|---|
| Standard Number | YY 9706.102-2021 |
| Chinese Title | Medical electrical equipment Part 1-2: General requirements for basic safety and essential performance Collateral standard: Electromagnetic compatibility Requirements and tests |
| English Title | Medical electrical equipment Part 1-2: General requirements for basic safety and essential performance Collateral standard: Electromagnetic compatibility Requirements and tests |
| Date of Issue | March 9, 2021 |
| Effective Date | May 1, 2023 |
| Issuing Authority | National Medical Products Administration |
| Standard Type | Mandatory industry standard |
YY 9706.102-2021 is the EMC collateral standard to GB 9706.1-2020. When a product-specific standard conflicts with this part, the product-specific standard prevails. The framework also relies on the GB/T 17626 immunity test series and CISPR-based emission standards to form a complete evaluation system.
| Related Standard | Role | Relationship |
|---|---|---|
| GB 9706.1-2020 | General safety foundation | YY 9706.102-2021 serves as its EMC collateral standard |
| GB/T 17626 series | Immunity test methods | Covers ESD, RS, EFT, Surge, CS and related tests |
| GB 4824 / CISPR 11 | Emission limit basis | Used for grouping, classification, and emission assessment |
| Product-specific safety standards | Supplementary requirements for specific devices | Take precedence if they conflict with this part |
Using YY 9706.102-2021 well requires more than memorizing test items. The real foundation is understanding the core concepts behind the standard, especially EMC, essential performance, and device grouping and classification.
| Concept | Key Meaning | Why It Matters |
|---|---|---|
| EMC | The ability to operate satisfactorily in the electromagnetic environment without introducing intolerable disturbance | Defines whether a device is both quiet enough and immune enough |
| Essential performance | Clinical performance whose loss or degradation would create unacceptable risk even if it is not identical to basic safety | Determines what must be monitored and judged during EMC testing |
| Life-supporting equipment | Equipment whose failure can directly threaten patient life | Affects test level selection and performance expectations |
| Grouping and classification | Division by RF use and operating environment, such as Group 1/2 and Class A/B | Affects emission limits and part of the environmental requirements |
The manufacturer must define, through risk management, which functions would create unacceptable risk if lost or degraded. For a monitor this may be measurement accuracy, for an infusion pump it may be flow control and alarms, and for a ventilator it may be ventilation output and alarm response.
Life-supporting equipment often demands stricter immunity performance. Class B devices, because they are intended for home or residential low-voltage networks, usually face tighter emission limits as well. These attributes should be decided early in project definition.
| Device Type | Examples of Essential Performance | Main EMC Focus |
|---|---|---|
| Multi-parameter monitor | Accuracy of heart rate, SpO2, and blood pressure measurement | Prevent measurement drift and false alarms |
| Infusion pump / syringe pump | Flow-rate accuracy, bolus output, alarm function | Prevent unintended delivery, false stop, or alarm loss |
| Ventilator | Ventilation output and alarm response | Maintain therapy continuity under disturbance |
| MRI / ultrasound | Image quality, resolution, and measurement functions | Avoid distortion of diagnostic information |
YY 9706.102-2021 directly links real use scenarios with EMC severity levels. The manufacturer must first declare the intended electromagnetic environment, then select appropriate test levels and justify that choice in the risk management file.
| Environment Category | Typical Locations | Environmental Characteristics |
|---|---|---|
| Professional healthcare facility environment | Hospitals, clinics, emergency departments, routine operating rooms | Professionally managed, equipment-dense, but relatively controlled |
| Home healthcare environment | Patient homes, nursing homes, day-care facilities | More consumer-electronics interference, less professional control, more complex power conditions |
| Special environment | Field hospitals, ambulances, military medical facilities | Conditions may exceed routine assumptions and need additional risk analysis |
| Environment with special electromagnetic sources | Areas near RF surgical devices, MRI, or radiotherapy equipment | High-intensity sources may require supplemental analysis and controls |
The same device may face different emission classification, ESD levels, installation instructions, and user warnings depending on whether it is intended for home use or professional healthcare use. This is not a wording issue in the IFU. It is a test-scope issue.
| Intended Environment | Radiated Immunity | Electrostatic Discharge | EFT | Emission Classification |
|---|---|---|---|---|
| Professional healthcare environment | 3 V/m | ±6 kV contact / ±8 kV air | ±2 kV on power ports | Class A or Class B |
| Home healthcare environment | 3 V/m | ±4 kV contact / ±8 kV air | ±1 kV on power ports | Class B |
| Special environment | Requires justification | Requires justification | Requires justification | Requires justification |
| Environment with special EM sources | Needs supplemental analysis | Needs supplemental analysis | Needs supplemental analysis | Needs supplemental analysis |
Many projects decide only right before testing whether the product should be evaluated for home or professional use. That decision directly affects sample configuration, applicable limits, failure probability, and document content. The correct approach is to declare the intended environment during product definition.
Emission tests evaluate how much electromagnetic disturbance the equipment generates during normal operation. For medical devices, emission control is not only a regulatory matter but also a coexistence issue with nearby medical equipment.
| Test Item | Frequency Range | Purpose | Common Standard Basis |
|---|---|---|---|
| Radiated emission, RE | 30 MHz-6 GHz | Evaluates disturbance radiated through space | GB 4824 / CISPR 11 |
| Conducted emission, CE | 150 kHz-30 MHz | Evaluates disturbance conducted onto power lines | GB 4824 / CISPR 11 |
| Harmonic current | 2nd to 40th harmonics | Limits harmonic current injected into the mains | GB 17625.1 |
| Voltage fluctuation and flicker | Evaluated against supply behavior | Avoids line fluctuation and flicker affecting other loads | GB/T 17625.2 |
Compared with YY 0505-2012, the upper limit for radiated emission expanded from 1 GHz to 6 GHz. This better covers modern wireless frequency bands such as Wi-Fi and Bluetooth, making EMC evaluation more realistic for current medical devices.
Switch-mode power supplies, rectifier stages, and high-speed digital circuits commonly couple high-frequency noise into the power interface. If input filtering is weak, CE is often the first test item to expose the problem.
| Item | Typical Failure Cause | Common Engineering Direction |
|---|---|---|
| Radiated emission | Clock harmonics, wireless modules, unintended antenna effects | Improve shielding, routing, terminations, and grounding |
| Conducted emission | Insufficient input filtering, switched-noise coupling | Add X/Y capacitors, common-mode chokes, and pi filters |
| Harmonic current | Weak power-factor correction and high rectifier harmonics | Use active PFC or harmonic mitigation modules |
| Flicker | Large inrush current or cyclic load fluctuation | Optimize power control, soft-start, and energy-storage design |
Without clarifying Group 1 or 2 and Class A or B, the correct emission limits cannot be selected.
Power supplies, wireless modules, and high-speed clocks are often the primary sources behind emission failures.
Filtering alone rarely solves all emission problems. Routing, shielding, and grounding must be improved at the same time.
Emission problems repeat across projects, so stable internal design rules matter more than repeated firefighting.
The real focus of immunity evaluation is not merely whether the device resets or freezes. It is whether essential performance drifts beyond acceptable limits during disturbance, and whether the device recovers automatically afterward. This is one of the most important upgrades in the new version.
| Test Item | Applicable Standard | Key Parameters | Purpose |
|---|---|---|---|
| Electrostatic discharge, ESD | GB/T 17626.2 | ±4 / 6 / 8 kV | Simulates static discharge from people and objects |
| Radiated immunity, RS | GB/T 17626.3 | 80 MHz-2.7 GHz, 3 V/m | Simulates wireless communication and base-station environments |
| EFT/Burst | GB/T 17626.4 | ±1 / 2 kV on power ports | Simulates relay and switching fast transients |
| Surge | GB/T 17626.5 | ±2 kV line-to-earth, ±1 kV line-to-line | Simulates lightning and power-switching overvoltage |
| Conducted immunity, CS | GB/T 17626.6 | 150 kHz-80 MHz, 3 V | Simulates RF disturbance coupled onto cables |
| Voltage dips and interruptions | GB/T 17626.11 | 0%-70% Ut | Simulates mains instability and dropouts |
| Power-frequency magnetic field | GB/T 17626.8 | 1-100 A/m | Simulates magnetic-field exposure at mains frequency |
Criterion A means normal performance during and after the test. Criterion B allows temporary degradation or loss during the test, but automatic recovery is required afterward. Criterion C means user intervention is needed for recovery. For essential performance, only A or B is acceptable.
If testing only checks whether the equipment stays powered on, real failures such as measurement drift, alarm loss, or therapy-output deviation can be missed. The new standard expects manufacturers to establish effective methods for monitoring critical performance continuously.
| Criterion | During Test | After Test | Expectation for Essential Performance |
|---|---|---|---|
| Criterion A | Normal performance | Normal performance | Required for the most critical situations |
| Criterion B | Temporary degradation or temporary loss | Automatic recovery | Acceptable only when no user intervention is needed |
| Criterion C | Degradation or loss | User intervention required | Not acceptable for essential performance |
The hardest part is not passing a single EMC test item. It is building a defensible chain of evidence around essential performance definition, monitoring methods, criteria selection, and recovery behavior that can support both registration review and real clinical use.
Many historical projects still follow YY 0505-2012 or habits formed under it. Understanding the differences between the two versions is essential for deciding whether test plans, sample definitions, and document templates need a real upgrade.
| Change Area | YY 0505-2012 | YY 9706.102-2021 |
|---|---|---|
| Standard logic | More centered on test items and outcomes | More centered on risk management and essential performance |
| Radiated emission range | 30 MHz-1 GHz | 30 MHz-6 GHz |
| Radiated immunity range | 80 MHz-2.5 GHz | 80 MHz-2.7 GHz |
| Modulation method | Mainly 1 kHz, 80% AM | Adds 217 Hz pulse modulation |
| Test-level selection | Radiated immunity often chosen between 3 V/m and 10 V/m | Uses 3 V/m as a base level, tied more clearly to environment declaration |
| Document requirements | More fragmented EMC instructions | More complete marking, declaration, and EMC guidance obligations |
At first glance, the bigger frequency ranges and new modulation methods are the most visible changes. The deeper shift is that EMC is now firmly integrated with risk management, essential performance, and user-document obligations.
If a company only replaces YY 0505-2012 test templates with YY 9706.102-2021 wording, but keeps the old logic for essential performance, environment declaration, warnings, and monitoring, the project may still face issues during registration review or remediation.
| Upgrade Direction | Impact on Manufacturers | Practical Action |
|---|---|---|
| Risk-management integration | EMC is no longer an isolated test activity | Establish EMC risk-management files |
| Essential-performance emphasis | Critical clinical functions must be defined and monitored | Define performance parameters and acceptable criteria |
| Expanded test coverage | Higher frequency bands and realistic wireless scenarios are now part of the picture | Verify that sample design and mitigation strategies cover the added range |
| Document updates | IFUs, technical files, and declarations must be revised together | Rework EMC guidance, separation information, and warnings |
To implement YY 9706.102-2021 effectively, it is not enough to understand the clauses. Sample preparation, test configuration, corrective-action closure, and document readiness all need to be planned together. This section is closer to an execution checklist.
Software version, accessories, cables, and operating modes should match registration materials and planned production reality.
Determine the strongest noise sources, most vulnerable modes, and most critical functions before formal testing starts.
EMC problems are highly repeatable, so PCB partitioning, filtering, shielding, and cable rules should become part of the standard design process.
Risk-management files, test plans, test reports, and manufacturer declarations should be built alongside testing rather than reconstructed afterward.
| Quick Reference | Content | Use Value |
|---|---|---|
| Appendix A | Overall test-item summary | Useful for a quick view of emission and immunity coverage |
| Appendix B | Performance-criteria quick reference | Helps internal review of test judgments |
| Appendix C | Environment-to-test-level mapping | Useful for aligning environment declaration and test scope |
| Appendix H | Comparison points versus YY 0505-2012 | Useful for gap analysis during a standard transition |
The key to implementing YY 9706.102-2021 is not simply running every EMC test item. It is building a complete evidence chain across intended environment, essential performance, monitoring methods, document obligations, and risk management so the result supports both registration review and real use conditions.
